Clinical trial
High Flow Nasal Oxygen Therapy in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure (AHRF)
NCT04109560 is registered in ClinicalTrials.gov with Argentinian Intensive Care Society as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High Flow Nasal Oxygen Therapy in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure (AHRF)
- Lead sponsor
- Argentinian Intensive Care Society
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2018
- Completion date
- September 30, 2019
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute hypercapnic respiratory failure, copd exacerbation, high flow oxygen therapy